Cytoprotective Effects of Antioxidant Peptides from Red Californian Worm (Eisenia foetida) Hydrolysate on Differentiated Caco-2 Cells
Nutrients · 27.10.2024 · 16 (21) · 3654
DOI: 10.3390/nu16213654 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 27.10.2024. Verfasst von Yhoan S Gaviria und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition and Food Technology Group, Faculty of Pharmaceutical and Food Sciences, University of Antioquia, Medellin 050010, Colombia. Hauptthemen laut MEDLINE: Antioxidants, Peptides, Oxidative Stress. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Tecnología e Innovación, MINCIENCIAS.
Abstract (Originalsprache)
Background/Objectives: When prooxidants outweigh antioxidants, oxidative stress can occur, causing an accumulation of reactive oxygen species (ROS). This process can lead to cellular damage and plays a role in the development of numerous health conditions. This study aimed to investigate the cytoprotective effects on differentiated Caco-2 cells of hydrolysates derived from the red Californian worm (WH) and their fractions, identify the peptides responsible for this effect, and elucidate the mechanisms involved.
Methods
The WH was obtained through hydrolysis with Alcalase 2.4 L and subsequently fractionated to two fractions (F > 3 kDa and F < 3 kDa) using a ceramic membrane with a molecular weight cutoff of 3 kDa. The peptides found in the F < 3 kDa fraction, demonstrating the highest cytoprotective activity, were then sequenced via liquid chromatography-mass spectrometry analysis (LC-MS/MS), and molecular docking was conducted to elucidate the underlying antioxidant mechanisms.
Results
The hydrolysate of Eisenia foetida and its F < 3 kDa fraction exhibited no cytotoxicity, protected the cells from H2O2-induced oxidative stress (50% increase viability), preserved cell viability by restoring their redox status (ROS: 20% decrease, and glutathione (GSH): recovered to basal control levels) and cell cycle distribution, and decreased apoptosis (16%). Twenty-eight peptides were identified, with five showing antioxidant activity through stable interactions with myeloperoxidase (MPO) and Kelch-like ECH-associated protein 1 (Keap-1), KPEDWDDR being the peptide that presented the highest affinity with both molecules (−7.9 and −8.8 kCal/mol, respectively).
Conclusions
These results highlight the WH as a potential source of bioactive peptides for the management of oxidative stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nutrition and Food Technology Group, Faculty of Pharmaceutical and Food Sciences, University of Antioquia, Medellin 050010, Colombia.
- Nutrition and Food Science Area, Faculty of Pharmacy and Food Sciences, University of Valencia, Avda. Vicente Andrés Estellés s/n, 46100 Burjassot, Valencia, Spain.
ORCID-Profile: Yhoan S Gaviria, José E Zapata, Diego Miedes, Antonio Cilla
Förderung
- Ministerio de Ciencia, Tecnología e Innovación
- MINCIENCIAS
Zitieren
APA
Gaviria, Y. S., Zapata, J. E., Miedes, D., Alegría, A., & Cilla, A. (2024). Cytoprotective Effects of Antioxidant Peptides from Red Californian Worm (Eisenia foetida) Hydrolysate on Differentiated Caco-2 Cells. Nutrients, 16(21), 3654. https://doi.org/10.3390/nu16213654
Vancouver
Gaviria YS, Zapata JE, Miedes D, Alegría A, Cilla A. Cytoprotective Effects of Antioxidant Peptides from Red Californian Worm (Eisenia foetida) Hydrolysate on Differentiated Caco-2 Cells. Nutrients. 2024;16(21):3654. doi:10.3390/nu16213654
BibTeX
@article{Gaviria2024,
author = {Gaviria, Yhoan S and Zapata, José E and Miedes, Diego and Alegría, Amparo and Cilla, Antonio},
title = {Cytoprotective Effects of Antioxidant Peptides from Red Californian Worm (Eisenia foetida) Hydrolysate on Differentiated Caco-2 Cells},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {21},
pages = {3654},
doi = {10.3390/nu16213654}
}
EUVIMED